Study says weight loss semaglutide jabs Wegovy, Ozempic and Rybelsus 'cut risk of heart attacks and strokes'
A five-year study involved 17,604 adults from 41 countries.
Full Article
Study says weight loss semaglutide jabs Wegovy, Ozempic and Rybelsus 'cut risk of heart attacks and strokes'
Bristol Post
0 shares
1 views
You might like
Related news coverage
Weight loss jabs could 'cut risk of heart attack or stroke', new study claims
Marketed as Wegovy, Ozempic and Rybelsus, semaglutide injections may benefit obese patients even if they don't lose weight.
Daily Record
Weight loss semaglutide jabs Wegovy, Ozempic and Rybelsus 'cut risk of heart attacks and strokes' says new study
A five-year study involved 17,604 adults from 41 countries
Wales Online